Key result
Reserpine-induced hypotension yields better hemodynamic adaptation than pentolinium and is potentiated by norepinephrine.
Why the study?
The study aimed to compare hemodynamic adaptations during reserpine-induced versus pentolinium-induced hypotension to understand differences related to onset gradation.
Does reserpine compared to pentolinium improve hemodynamic adaptation during induced hypotension in humans?
Does reserpine compared to pentolinium improve hemodynamic adaptation during induced hypotension in humans?
Reserpine provides better hemodynamic adaptation than pentolinium during induced hypotension, with distinct potentiation profiles by norepinephrine and serotonin.
May favor reserpine for induced hypotension; leaves open relevance to modern agents and practice.
Comparison of hemodynamic changes (cardiac output, renal plasma flow, and extremity blood flow) observed during reserpine-induced hypotension with those occurring during pentolinium-induced hypotension suggests better adaptation following reserpine. This difference is believed to be related to the gradation of onset of hypotension. It was found that reserpine-induced hypotension is potentiated by norepinephrine, and pentolinium-induced hypotension by serotonin. Pretreatment with the hypotensive agent increased the pressor response to norepinephrine and serotonin respectively, if the pressor substance was administered before the onset of hypotension.
No takes yet. Share an insight, caveat, or question.
Redisch et al. (1958) studied this question. Reserpine vs. Pentolinium was evaluated on Hemodynamic changes (cardiac output, renal plasma flow, and extremity blood flow). Reserpine-induced hypotension demonstrated better hemodynamic adaptation compared to pentolinium-induced hypotension, and was potentiated by norepinephrine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: